BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34785398)

  • 1. Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients.
    Rubinstein JD; Jodele S; Heyenbruch D; Wilhelm J; Thomas S; Lutzko C; Zhu X; Leemhuis T; Cancelas JA; Keller M; Bollard CM; Hanley PJ; Boghdadly ZE; Mims A; Davies SM; Grimley MS; Nelson AS
    Transplant Cell Ther; 2022 Feb; 28(2):116.e1-116.e7. PubMed ID: 34785398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-Party and Patient-Specific Donor-Derived Virus-Specific T Cells Demonstrate Similar Efficacy and Safety for Management of Viral Infections after Hematopoietic Stem Cell Transplantation in Children and Young Adults.
    Galletta TJ; Lane A; Lutzko C; Leemhuis T; Cancelas JA; Khoury R; Wang YM; Hanley PJ; Keller MD; Bollard CM; Davies SM; Grimley MS; Rubinstein JD
    Transplant Cell Ther; 2023 May; 29(5):305-310. PubMed ID: 36736781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
    Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
    PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
    Shimbo E; Nukuzuma S; Tagawa YI
    Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK Is a Critical Regulator of JC Polyomavirus Infection.
    DuShane JK; Wilczek MP; Mayberry CL; Maginnis MS
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
    Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
    Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JC Polyomavirus Infection Reveals Delayed Progression of the Infectious Cycle in Normal Human Astrocytes.
    Wilczek MP; DuShane JK; Armstrong FJ; Maginnis MS
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JC polyomavirus viremia and progressive multifocal leukoencephalopathy in human leukocyte antigen-sensitized kidney transplant recipients desensitized with intravenous immunoglobulin and rituximab.
    Toyoda M; Thomas D; Ahn G; Kahwaji J; Mirocha J; Chu M; Vo A; Suviolahti E; Ge S; Jordan SC
    Transpl Infect Dis; 2015 Dec; 17(6):838-47. PubMed ID: 26437369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot study.
    Cortese I; Beck ES; Al-Louzi O; Ohayon J; Andrada F; Osuorah I; Dwyer J; Billioux BJ; Dargah-Zada N; Schindler MK; Binder K; Reoma L; Norato G; Enose-Akahata Y; Smith BR; Monaco MC; Major EO; Jacobson S; Stroncek D; Highfill S; Panch S; Reich DS; Barrett J; Nath A; Muranski P
    Lancet Neurol; 2021 Aug; 20(8):639-652. PubMed ID: 34302788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.
    Tzannou I; Papadopoulou A; Naik S; Leung K; Martinez CA; Ramos CA; Carrum G; Sasa G; Lulla P; Watanabe A; Kuvalekar M; Gee AP; Wu MF; Liu H; Grilley BJ; Krance RA; Gottschalk S; Brenner MK; Rooney CM; Heslop HE; Leen AM; Omer B
    J Clin Oncol; 2017 Nov; 35(31):3547-3557. PubMed ID: 28783452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
    Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
    mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature.
    Kharfan-Dabaja MA; Ayala E; Greene J; Rojiani A; Murtagh FR; Anasetti C
    Bone Marrow Transplant; 2007 Jan; 39(2):101-7. PubMed ID: 17143300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy.
    Nelson AS; Yalamarthi N; Yong MK; Blyth E
    Curr Opin Infect Dis; 2021 Dec; 34(6):627-634. PubMed ID: 34751182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JC polyomavirus DNA detection in clinical practice.
    Kartau M; Auvinen E; Verkkoniemi-Ahola A; Mannonen L; Helanterä I; Anttila VJ
    J Clin Virol; 2022 Jan; 146():105051. PubMed ID: 34883406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients.
    Nelson AS; Heyenbruch D; Rubinstein JD; Sabulski A; Jodele S; Thomas S; Lutzko C; Zhu X; Leemhuis T; Cancelas JA; Keller M; Bollard CM; Hanley PJ; Davies SM; Grimley MS
    Blood Adv; 2020 Nov; 4(22):5745-5754. PubMed ID: 33216887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient.
    Balduzzi A; Lucchini G; Hirsch HH; Basso S; Cioni M; Rovelli A; Zincone A; Grimaldi M; Corti P; Bonanomi S; Biondi A; Locatelli F; Biagi E; Comoli P
    Bone Marrow Transplant; 2011 Jul; 46(7):987-92. PubMed ID: 20921942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient.
    Bialasiewicz S; Hart G; Oliver K; Agnihotri SP; Koralnik IJ; Viscidi R; Nissen MD; Sloots TP; Burke MT; Isbel NM; Burke J
    Transplantation; 2017 Jun; 101(6):1461-1467. PubMed ID: 27367472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy.
    Berzero G; Basso S; Stoppini L; Palermo A; Pichiecchio A; Paoletti M; Lucev F; Gerevini S; Rossi A; Vegezzi E; Diamanti L; Bini P; Gastaldi M; Delbue S; Perotti C; Seminari E; Faraci M; Luppi M; Baldanti F; Zecca M; Marchioni E; Comoli P
    Ann Neurol; 2021 Apr; 89(4):769-779. PubMed ID: 33459417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JC polyomavirus reactivation is common following allogeneic stem cell transplantation and its preemptive detection may prevent lethal complications.
    Wittmann T; Horowitz N; Benyamini N; Henig I; Zuckerman T; Rowe JM; Kra-Oz Z; Szwarcwort Cohen M; Oren I; Avivi I
    Bone Marrow Transplant; 2015 Jul; 50(7):984-91. PubMed ID: 25867649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive multifocal leukoencephalopathy: a rare infectious complication following allogeneic hematopoietic cell transplantation (HCT).
    Kaufman GP; Aksamit AJ; Klein CJ; Yi ES; Delone DR; Litzow MR
    Eur J Haematol; 2014 Jan; 92(1):83-7. PubMed ID: 24118404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.